Huang HJ - Search Results

1

Replacement of the p16/CDKN2 gene suppresses human glioma cell growth.

Arap W, Nishikawa R, Furnari FB, Cavenee WK, Huang HJ. Arap W, et al. Among authors: huang hj. Cancer Res. 1995 Mar 15;55(6):1351-4. Cancer Res. 1995. PMID: 7882335

2

Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells.

Van Meir EG, Roemer K, Diserens AC, Kikuchi T, Rempel SA, Haas M, Huang HJ, Friedmann T, de Tribolet N, Cavenee WK. Van Meir EG, et al. Among authors: huang hj. Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1008-12. doi: 10.1073/pnas.92.4.1008. Proc Natl Acad Sci U S A. 1995. PMID: 7862624 Free PMC article.

3

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.

Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK, Huang HJ. Nishikawa R, et al. Among authors: huang hj. Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7727-31. doi: 10.1073/pnas.91.16.7727. Proc Natl Acad Sci U S A. 1994. PMID: 8052651 Free PMC article.

4

The p53 gene and its role in human brain tumors.

Bögler O, Huang HJ, Kleihues P, Cavenee WK. Bögler O, et al. Among authors: huang hj. Glia. 1995 Nov;15(3):308-27. doi: 10.1002/glia.440150311. Glia. 1995. PMID: 8586466 Review.

5

Genetics and malignant progression of human brain tumours.

Furnari FB, Huang HJ, Cavenee WK. Furnari FB, et al. Among authors: huang hj. Cancer Surv. 1995;25:233-75. Cancer Surv. 1995. PMID: 8718522 Review.

6

Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors.

Han Y, Caday CG, Nanda A, Cavenee WK, Huang HJ. Han Y, et al. Among authors: huang hj. Cancer Res. 1996 Sep 1;56(17):3859-61. Cancer Res. 1996. PMID: 8752145

7

A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis.

Nagane M, Coufal F, Lin H, Bögler O, Cavenee WK, Huang HJ. Nagane M, et al. Among authors: huang hj. Cancer Res. 1996 Nov 1;56(21):5079-86. Cancer Res. 1996. PMID: 8895767

8

Point mutations can inactivate in vitro and in vivo activities of p16(INK4a)/CDKN2A in human glioma.

Arap W, Knudsen ES, Wang JY, Cavenee WK, Huang HJ. Arap W, et al. Among authors: huang hj. Oncogene. 1997 Feb 6;14(5):603-9. doi: 10.1038/sj.onc.1200870. Oncogene. 1997. PMID: 9053859

9

Functional analysis of wild-type and malignant glioma derived CDKN2Abeta alleles: evidence for an RB-independent growth suppressive pathway.

Arap W, Knudsen E, Sewell DA, Sidransky D, Wang JY, Huang HJ, Cavenee WK. Arap W, et al. Among authors: huang hj. Oncogene. 1997 Oct 23;15(17):2013-20. doi: 10.1038/sj.onc.1201389. Oncogene. 1997. PMID: 9366518

10

The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells.

Furnari FB, Huang HJ, Cavenee WK. Furnari FB, et al. Among authors: huang hj. Cancer Res. 1998 Nov 15;58(22):5002-8. Cancer Res. 1998. PMID: 9823298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

938 results

Search Page

Filters